PAXMAN announces proposal for Local Coverage Determination of scalp cooling therapy

Highlights:

• PAXMAN announces that the Palmetto Medicare Administrative Contractor (MAC) has issued a Proposed Local Coverage Determination (LCD) for Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia, recommending coverage for FDA cleared devices.
• This is the first proposed LCD for scalp cooling, marking a significant advancement in support for healthcare providers to receive reimbursement from Medicare for administering scalp cooling therapy.
• The proposed scalp cooling LCD will undergo public review and be discussed at Open Meetings of the Palmetto GBA. If approved, it would establish a pathway for successful reimbursement of Medicare scalp cooling claims in the service area by early 2024.